Research & Literature
Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.
Top Authors
Top Institutions
Finding nearby institutions...
Inserm
Paris, France
Bambino Gesù Children's Hospital
Rome, Italy
Sichuan University
Chengdu, China
Razi Hospital
Tehran, Iran
University of Lübeck
Lübeck, Germany
BGI Group (China)
Shenzhen, China
Philipps University of Marburg
Marburg, Germany
LMU Klinikum
Munich, Germany
University of Pennsylvania
Philadelphia, United States
National Institutes of Health
Bethesda, United States
References
References (57)
- 1
A retrospective study of antihypertensives in pemphigus: a still unchartered odyssey particularly between thiols, amides and phenols.
Pietkiewicz P, Gornowicz-Porowska J, Bowszyc-Dmochowska M, Dmochowski M
Archives of medical science : AMS 2015; (11(5)):1021-7 doi:10.5114/aoms.2015.54857.
PMID: 26528346 - 2
Comparative study of indirect immunofluorescence, enzyme-linked immunosorbent assay, and the Tzanck smear test for the diagnosis of pemphigus.
Zhou T, Fang S, Li C, Hua H
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2016; (45(10)):786-790 doi:10.1111/jop.12439.
PMID: 27005471 - 3
Pemphigus foliaceus exacerbated by radiation, in association with myasthenia gravis.
Liebman TN, Lieberman MR, Burris K
Dermatology online journal 2016; (22(3)).
PMID: 27136623 - 4
Systemic lupus erythematosus associated with myasthenia gravis, pemphigus foliaceus and chronic thyroiditis after thymectomy.
Sawamura S, Kajihara I, Makino K, et al.
The Australasian journal of dermatology 2017; (58(3)):e120-e122 doi:10.1111/ajd.12510.
PMID: 27270472 - 5
- 6
Pemphigus Vulgaris and Pemphigus Foliaceus: Differences in Epidemiology and Mortality.
Kridin K, Zelber-Sagi S, Bergman R
Acta dermato-venereologica 2017; (97(9)):1095-1099 doi:10.2340/00015555-2706.
PMID: 28536732 - 7
Insights into the epidemiological link between biting flies and pemphigus foliaceus in southeastern Brazil.
Vernal S, Pepinelli M, Casanova C, et al.
Acta tropica 2017; (176()):455-462 doi:10.1016/j.actatropica.2017.09.015.
PMID: 28941730 - 8
A prospective study comparing patients with early and late relapsing pemphigus treated with rituximab.
Saleh MA
Journal of the American Academy of Dermatology 2018; (79(1)):97-103 doi:10.1016/j.jaad.2018.01.029.
PMID: 29408700 - 9
Pemphigus foliaceus worsened by drugs in a patient with psoriasis, responding to adalimumab.
Sanz-Bueno J, Gallo E, Caro-Gutiérrez D, et al.
Dermatology online journal 2017; (23(10)).
PMID: 29469785 - 10
Psoriasiform Pemphigus Foliaceus in an African American Female: An Important Clinical Manifestation.
Austin E, Millsop JW, Ely H, et al.
Journal of drugs in dermatology : JDD 2018; (17(4)):471-473.
PMID: 29601624 - 11
Incidence of pemphigus vulgaris and pemphigus foliaceus in North-East Poland (Podlaskie Province) - a 15-year (2001-2015) bicentric retrospective study.
Serwin AB, Koper M, Flisiak I
International journal of dermatology 2018; (57(8)):933-937 doi:10.1111/ijd.14078.
PMID: 29873080 - 12
Feline pemphigus foliaceus in non-specialist veterinary practice: a retrospective analysis.
Coyner K, Tater K, Rishniw M
The Journal of small animal practice 2018; (59(9)):553-559 doi:10.1111/jsap.12869.
PMID: 29961990 - 13
Fogo selvagem: endemic pemphigus foliaceus.
Hans-Filho G, Aoki V, Bittner NRH, Bittner GC
Anais brasileiros de dermatologia 2018; (93(5)):638-650 doi:10.1590/abd1806-4841.20188235.
PMID: 30156612 - 14
Subtype-specific inherited predisposition to pemphigus in the Chinese population.
Zhang SY, Zhou XY, Zhou XL, et al.
The British journal of dermatology 2019; (180(4)):828-835 doi:10.1111/bjd.17191.
PMID: 30230522 - 15
Enzyme-linked immunosorbent assay as a helpful diagnostic tool for pemphigus erythematosus with equivocal histologic and immunofluorescent findings.
Desai A, Harris J, Motaparthi K
Dermatology online journal 2018; (24(8)).
PMID: 30677852 - 16
Improving Treatment Outcome of Pemphigus Vulgaris on Vietnamese Patients by Using Desmoglein Elisa Test.
Van ATT, Nguyen TV, Huu SN, et al.
Open access Macedonian journal of medical sciences 2019; (7(2)):195-197 doi:10.3889/oamjms.2019.003.
PMID: 30745956 - 17
Pemphigus subtype: a confounder in determining the association of oral involvement with post-rituximab relapses.
Kneiber D, Kowalski EH, Kridin K, Amber KT
Dermatologic therapy 2019; (32(3)):e12918 doi:10.1111/dth.12918.
PMID: 30977210 - 18
Non-endemic erythrodermic pemphigus foliaceus: a case with delayed diagnosis and response to rituximab.
Patsatsi A, Kyriakou A, Douma S, et al.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2019; (17(5)):537-539 doi:10.1111/ddg.13836.
PMID: 30994241 - 19
[Possible effect of interleukin-17 blockade in pemphigus foliaceus and neutrophilic diseases].
Kohlmann J, Simon JC, Kunz M, Treudler R
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 2019; (70(8)):641-644 doi:10.1007/s00105-019-4414-8.
PMID: 31076811 - 20
Role of Dsg1- and Dsg3-Mediated Signaling in Pemphigus Autoantibody-Induced Loss of Keratinocyte Cohesion.
Walter E, Vielmuth F, Wanuske MT, et al.
Frontiers in immunology 2019; (10()):1128 doi:10.3389/fimmu.2019.01128.
PMID: 31178865 - 21
Prolonged Impairment of Immunological Memory After Anti-CD20 Treatment in Pediatric Idiopathic Nephrotic Syndrome.
Colucci M, Carsetti R, Serafinelli J, et al.
Frontiers in immunology 2019; (10()):1653 doi:10.3389/fimmu.2019.01653.
PMID: 31379849 - 22
Endocytosis of IgG, Desmoglein 1, and Plakoglobin in Pemphigus Foliaceus Patient Skin.
Oktarina DAM, Sokol E, Kramer D, et al.
Frontiers in immunology 2019; (10()):2635 doi:10.3389/fimmu.2019.02635.
PMID: 31781120 - 23
Pemphigus Vulgaris and Foliaceus IgG Autoantibodies Directly Block Heterophilic Transinteraction between Desmoglein and Desmocollin.
Ishii K, Yoshida K, Stanley JR, et al.
The Journal of investigative dermatology 2020; (140(10)):1919-1926.e7 doi:10.1016/j.jid.2020.02.010.
PMID: 32142800 - 24
The ISCCA flow protocol for the monitoring of anti-CD20 therapies in autoimmune disorders.
Gatti A, Buccisano F, Scupoli MT, Brando B
Cytometry. Part B, Clinical cytometry 2021; (100(2)):194-205 doi:10.1002/cyto.b.21930.
PMID: 32598578 - 25
Epidemiology and Factors Associated with Remission of Pemphigus Vulgaris and Foliaceus in Singapore.
Cai SC, Zhao X, Tang MB, Lim YL
Annals of the Academy of Medicine, Singapore 2020; (49(6)):367-376.
PMID: 32712634 - 26
Pemphigus foliaceus in a patient with gastrointestinal stromal tumor treated with adjuvant imatinib mesylate.
Lewis HA, Chen DY, Rosman IS, et al.
Dermatology online journal 2020; (26(6)).
PMID: 32815695 - 27
B-cell targeted therapies in pemphigus.
Maglie R, Antiga E, Payne AS
Italian journal of dermatology and venereology 2021; (156(2)):161-173 doi:10.23736/S2784-8671.20.06694-8.
PMID: 33016669 - 28
Toll-like-Receptor Gene Polymorphisms in Tunisian Endemic Pemphigus Foliaceus.
Abida O, Bahloul E, Elloumi N, et al.
BioMed research international 2020; (2020()):6541761 doi:10.1155/2020/6541761.
PMID: 33204706 - 29
Anti-CD20 monoclonal antibodies in Systemic Lupus Erythematosus.
Shah K, Cragg M, Leandro M, Reddy V
Biologicals : journal of the International Association of Biological Standardization 2021; (69()):1-14 doi:10.1016/j.biologicals.2020.11.002.
PMID: 33288390 - 30
Rituximab Therapy for Treatment of Pemphigus in Southeast Asians.
Kanokrungsee S, Anuntrangsee T, Tankunakorn J, et al.
Drug design, development and therapy 2021; (15()):1677-1690 doi:10.2147/DDDT.S306046.
PMID: 33911853 - 31
Safety, Tolerability, and Activity of ALXN1830 Targeting the Neonatal Fc Receptor in Chronic Pemphigus.
Werth VP, Culton DA, Concha JSS, et al.
The Journal of investigative dermatology 2021; (141(12)):2858-2865.e4 doi:10.1016/j.jid.2021.04.031.
PMID: 34126109 - 32
Differentiating Pemphigus Foliaceus From Pemphigus Vulgaris in Clinical Practice.
Stumpf N, Huang S, Hall LD, Hsu S
Cureus 2021; (13(9)):e17889 doi:10.7759/cureus.17889.
PMID: 34548989 - 33
A retrospective evaluation of the steroid sparing effects of oral mycophenolate mofetil (MMF) as an adjunct immunosuppressant for the treatment of canine pemphigus foliaceus.
Putra A, Austel M, Banovic F
Veterinary dermatology 2022; (33(1)):77-e24 doi:10.1111/vde.13028.
PMID: 34697841 - 34
An unusual presentation of pemphigus foliaceus following COVID-19 vaccination.
Lua ACY, Ong FLL, Choo KJL, et al.
The Australasian journal of dermatology 2022; (63(1)):128-130 doi:10.1111/ajd.13755.
PMID: 34817063 - 35
Invasive breast cancer found in a patient with new-onset pemphigus foliaceus.
Liu L, Deng J, Cibull T, Pesce CE
JAAD case reports 2021; (18()):67-70 doi:10.1016/j.jdcr.2021.10.014.
PMID: 34841027 - 36
New-onset pemphigus foliaceus following SARS-CoV-2 infection and unmasking multiple sclerosis: A case report.
Mohaghegh F, Hatami P, Refaghat A, et al.
Clinical case reports 2022; (10(6)):e05910 doi:10.1002/ccr3.5910.
PMID: 35662780 - 37
Ocrelizumab, an alternative to rituximab in refractory pemphigus vulgaris management.
de-la-Rosa-Fernández E, Loizate-Sarrionandia I, González-Rodríguez J, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2023; (37(9)):e1104-e1106 doi:10.1111/jdv.19133.
PMID: 37102356 - 38
Localized Pemphigus Foliaceus: Diverse Presentations, Treatment, and Review of the Literature.
Kunadia A, Moschella S, McLemore J, Sami N
Indian journal of dermatology 2023; (68(1)):123 doi:10.4103/ijd.ijd_324_22.
PMID: 37151255 - 39
Juvenile Pemphigus Foliaceus in a Patient With Psoriasis Receiving Narrow-Band Ultraviolet-B: Successful Treatment With Rituximab.
Yousif J, Gottlieb AB, Al-Dehneem R
Journal of drugs in dermatology : JDD 2023; (22(8)):830-831 doi:10.36849/jdd.7241.
PMID: 37556511 - 40
The landscape of the immunoglobulin repertoire in endemic pemphigus foliaceus.
Calonga-Solís V, Olbrich M, Ott F, et al.
Frontiers in immunology 2023; (14()):1189251 doi:10.3389/fimmu.2023.1189251.
PMID: 37575223 - 41
Treatment of Pediatric Pemphigus Foliaceus.
Carver C, Kalesinskas M, Dheden N, Ahmed AR
Cureus 2023; (15(9)):e45373 doi:10.7759/cureus.45373.
PMID: 37779684 - 42
Pemphigus Foliaceus after COVID-19 Vaccination: A Report of Two Cases.
Pham NN, Nguyen TTP, Vu TTP, Nguyen HT
Case reports in dermatological medicine 2023; (2023()):1218388 doi:10.1155/2023/1218388.
PMID: 37900286 - 43
Sporadic Pemphigus Foliaceus in a 3-Year-Old Vietnamese Girl: A Case Report and Literature Review.
Nguyen TTD, Chau TNT, Doan Vo PT, Nguyen HT
Case reports in dermatological medicine 2024; (2024()):6748340 doi:10.1155/2024/6748340.
PMID: 38404530 - 44
Eye and lid involvement as an uncommon feature of pemphigus foliaceus in a pediatric patient.
Garza-Dávila VF, Santana-Gutiérrez A, Zapata-Salazar N, et al.
Pediatric dermatology 2024; (41(5)):853-856 doi:10.1111/pde.15594.
PMID: 38459607 - 45
Red crusty plaques in a young man.
Farsi M, Johnson CM, Segars K, Rhim J
Dermatology online journal 2023; (29(5)) doi:10.5070/D329562411.
PMID: 38478647 - 46
Localized facial pemphigus foliaceus presenting in a dermatomal distribution: A case report.
Couture-Lapointe C, Rousseau-Théberge M
SAGE open medical case reports 2024; (12()):2050313X241284113 doi:10.1177/2050313X241284113.
PMID: 39318656 - 47
A Case of Recurrent Pemphigus Foliaceus Following Noncompliance to Medication.
Ali M, Ahmad MH, Imran A, et al.
Clinical case reports 2024; (12(11)):e9622 doi:10.1002/ccr3.9622.
PMID: 39582723 - 48
Risk of Osteoporosis Associated with Glucocorticoid Use in Pemphigus Vulgaris: Insights from a Retrospective Cohort Study.
Kaya M, Saraç GA, Acar O, et al.
Dermatology practical & conceptual 2025; (15(2)) doi:10.5826/dpc.1502a5050.
PMID: 40401897 - 49
Drug-Induced Pemphigus Foliaceus Potentially Triggered by Piperacillin-Tazobactam, Linezolid, and Additional Factors: A Report of a Rare Case.
Holi A, Rijal S, Rayamajhi S, Regmi N
Cureus 2025; (17(5)):e85144 doi:10.7759/cureus.85144.
PMID: 40599502 - 50
Clinicodemographic characteristics of pemphigus foliaceus: retrospective analysis of clinic-based data for 103 patients in a nonendemic location.
De D, Sharma A, Hanumanthu V, et al.
Clinical and experimental dermatology 2026; (51(5)):840-845 doi:10.1093/ced/llaf408.
PMID: 40931562 - 51
Clinical and Immunological Outcomes of Rituximab Therapy in Pemphigus: A Prospective Observational Study.
Deo KS, Mishra N, Singh Deora M, et al.
Dermatology (Basel, Switzerland) 2026; (242(2)):145-151 doi:10.1159/000550170.
PMID: 41442437 - 52
Clinical correlation of anti-desmoglein antibody dynamics in pemphigus treated with rituximab.
Naidu V, Jain HA, Yalcinkaya A, et al.
Frontiers in immunology 2025; (16()):1713987 doi:10.3389/fimmu.2025.1713987.
PMID: 41459496 - 53
Emerging Treatments in Pemphigus: Is Healing an Achievable Goal?
Horváth B, Hiel MAJ, Strandmoe AL, Meijer JM
American journal of clinical dermatology 2026; (27(2)):317-327 doi:10.1007/s40257-025-01002-1.
PMID: 41460304 - 54
Pemphigus Foliaceus Mimicking Erythema Annulare Centrifugum: A Case Report.
Kobayashi T, Iinuma S, Fujita Y
Cureus 2026; (18(1)):e100813 doi:10.7759/cureus.100813.
PMID: 41646576 - 55
A diagnostically challenging case of pemphigus foliaceus without histologic evidence of acantholysis.
Liu JY, Scumpia P, Ni C, et al.
Dermatology online journal 2026; (32(1)) doi:10.25251/4gj9fp73.
PMID: 42246332 - 56
Atypical pemphigus foliaceus with pustular lesions: a case series.
Pangastuti M, Sundani A, Suwarsa O, et al.
Journal of medical case reports 2026; (20(1)).
PMID: 42343341 - 57
Efficacy and Safety of Rituximab in Pemphigus Foliaceus: A Systematic Review and Meta-analysis.
Kieffer C, Hebert V, Joly P, Tedbirt B
Dermatology and therapy 2026; doi:10.1007/s13555-026-01811-0.
PMID: 42390708